1873 — VIVA Biotech Holdings Share News
0.000.00%
Last trade - 00:00- HK$2.68bn
- HK$2.54bn
- CNY1.73bn
VIVA Biotech falls on plan to sell unit's stake, convertible bonds issue
Brief: Viva Biotech Posts FY Net Loss RMB504.2 Million
Brief: Viva Biotech Sees Revenue To Increase By Over 13% For Year
Brief: Viva Biotech Repurchases Of Us$29.9 Million Of $180 Mln Guaranteed Convertible Bonds
Brief: Viva Biotech Reports HY Adjusted Non-IFRS Net Profit RMB89.0 Million
Brief: Viva Biotech Sees HY Net Loss Of Not More Than Rmb100 Mln
Brief: Viva Biotech Posts FY Adjusted Non-IFRS Net Profit Of RMB352.5 Million
Brief: VIVA Biotech Announces Reset Of Conversion Price Of 2.50% Guaranteed Convertible Bonds Due 2025
Brief: Viva Biotech Reset Of Conversion Price Of 2.50 Per Cent. Guaranteed Convertible Bonds Due 2025
Brief: Viva Biotech Holdings Posts HY Net Profit RMB 95.8 MLN
Brief: VIVA Biotech Says Ban Yan To Be Named Chair Of Zhejiang Langhua Pharmaceutical
Brief: Viva Biotech Holdings Sees A Net Profit Of No Less Than RMB85 Million For Six Months
Brief: Viva Biotech's Shareholder Sold 40 Mln H-Shares In The Company On July 14 - HKEX Filing
Brief: Viva Biotech Holdings Says Hua Fengmao Tendered His Resignation As Executive Director
Brief: Viva Biotech Holdings Says Wang Zheren Will Be Appointed As CFO
Brief: Viva Biotech Holdings Recommended Payment Of A Final Dividend Of HK$0.01 Per Share
Brief: Viva Biotech Sees Net Loss For Year To Be No Higher Than RMB400 Mln
Brief: Viva Biotech Sees Significant Amount Of Net Loss During Year
Brief: Viva Biotech Holdings Says Unit's Proposal To Establish 3 Production Plants Approved